Ontology highlight
ABSTRACT: Background
Effective therapeutic management of elderly patients with cancer, on an individual basis, remains a clinical challenge. Here, we identify novel biomarkers to assess elderly patients (≥70 years of age) with breast cancer undergoing treatment with or without chemotherapy.Methods
We performed comprehensive geriatric assessment and measured markers sensitive to alteration in ageing, including leukocyte telomere length, CMV serostatus, levels of circulating growth factors and cytokines, and immune profiling of T cell and myeloid populations in blood before and at 3 months and 12 months after initiation of therapy, using flow cytometry.Results
We observed changes in immune profiles over time that were specific to patients receiving chemotherapy; these patients
SUBMITTER: Bailur JK
PROVIDER: S-EPMC5330012 | biostudies-literature | 2017 Feb
REPOSITORIES: biostudies-literature